8 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 3, May/June 2018
138
AFRICA
myocardial fibrosis and oedema, without dependence on the
presence of adequate acoustic windows and operator experience.
5
CMR may provide additional diagnostic information when
echocardiographic imaging is suboptimal. However, the utility
of CMR for the evaluation of RHD may be limited by its
relative inability to be used in patients with certain types
of metallic implants, local artefacts from prosthetic valves,
lack of availability, expense of the tests and limited expertise
in RHD-endemic countries. Furthermore, data regarding
prognostic significance of CMR in RHD are lacking.
5
I gratefully acknowledge support from the National Research Foundation
and the Medical Research Council of South Africa, National Heart, Lung
and Blood Institute in the USA, as well as the Harry Crossley Foundation.
References
1.
Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A,
Bukhman G,
et al
. Global, regional, and national burden of rheumatic
heart disease, 1990–2015.
New Engl J Med
2017;
377
(8): 713–722.
2.
Abubakar II, Tillmann T, Banerjee A, for the GBD 2013 Mortality and
Causes of Death Collaborators. Global, regional, and national age-sex
specific all-cause and cause-specific mortality for 240 causes of death,
1990–2013: a systematic analysis for the Global Burden of Disease
Study 2013.
Lancet
2015;
385
(9963): 117–171.
3.
Mocumbi AO. Rheumatic heart disease in Africa: is there a role for
genetic studies?
Cardiovasc J Afr
2015;
26
(2 Suppl 1): S21–S26.
4.
Rothenbühler M, O’Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E,
Estill J,
et al
. Active surveillance for rheumatic heart disease in endemic
regions: a systematic review and meta-analysis of prevalence among
children and adolescents.
Lancet Global Health
2014;
2
(12): e717–e726.
5.
Zühlke LJ, Beaton A, Engel ME, Hugo-Hamman CT, Karthikeyan G,
Katzenellenbogen JM,
et al
. Group A Streptococcus, acute rheumatic
fever and rheumatic heart disease: epidemiology and clinical considera-
tions.
Curr Treat Options Cardiovasc Med
2017;
19
(2): 15.
6.
Sood V, Jermy S, Saad H, Samuels P, Moosa S, Ntusi NAB. Review of
cardiovascular magnetic resonance in human immunodeficiency virus-
associated cardiovascular disease.
S Afr J Radiol
2017;
21
(2): 10.
7.
Ntusi NA, Samuels P, Moosa S, Mocumbi AO. Diagnosing cardiac
disease during pregnancy: imaging modalities.
Cardiovasc J Afr
2016;
27
(2): 96–103.
8.
Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews
PM,
et al
. Subclinical myocardial inflammation and diffuse fibrosis
are common in systemic sclerosis – a clinical study using myocar-
dial T1-mapping and extracellular volume quantification.
J Cardiovasc
Magnetic Resonance
2014;
16
: 21.
9.
Ferreira VM, Piechnik SK, Dall’Armellina E, Karamitsos TD, Francis
JM, Ntusi N,
et al
. T(1) mapping for the diagnosis of acute myocarditis
using CMR: comparison to T2-weighted and late gadolinium enhanced
imaging.
J Am Coll Cardiol Cardiovasc Imag
2013;
6
(10): 1048–1058.
10. Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM,
Robson MD,
et al
. Diffuse myocardial fibrosis and inflammation in
rheumatoid arthritis: insights from CMR T1 mapping.
J Am Coll
Cardiol Cardiovasc Imag
2015;
8
(5): 526–536.
11. Lang RM, Mor-Avi V, Sugeng L, Nieman PS, Sahn DJ. Three-
dimensional echocardiography: the bnefits and additional dimension.
J
Am Coll Cardiol
2006;
48
(10): 2053–2069.
12. Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K,
et al
.
World Heart Federation criteria for echocardiographic diagnosis of
rheumatic heart disease – an evidence-based guideline.
Nature Rev
Cardiol
2012;
9
(5): 297–309.
13. Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance
imaging for valvular heart disease: technique and validation.
Circulation
2009;
119
(3): 468–478.
14. Shriki J,
Talkin B, Thomas IC, Farvid A, Colletti PM. Delayed gado-
linium enhancement in the atrial wall: a novel finding in 3 patients with
rheumatic heart disease.
Texas Heart Inst J
2011;
38
(1): 56–60.
15. Mutnuru PC, Singh SN, D’Souza J, Perubhotla LM. Cardiac MR
imaging in the evaluation of rheumatic valvular heart diseases.
J Clin
Diagnost Res
2016;
10
(3): TC06–TC09.
16. Samuels P, Chin A, Ntsekhe M, Ntusi NAB. CMR unravels the
pathophysiology of heart block in a young woman.
Cardiovasc Magnet
Resonance Congress S Afr
2017 (abstract).
http://www.cubic.uct.ac.za/sites/default/files/image_tool/images/217/SCMR%20Abstract%20Petty.
pdf. Accessed 8 June 2018.
17. Edwards NC, Moody WE, Yuan M, Weale P, Neal D, Townend JN,
et
al
. Quantification of left ventricular interstitial fibrosis in asymptomatic
chronic primary degenerative mitral regurgitation.
Circ Cardiovasc Imag
2014;
7
: 946–953.
18. Meel R, Nethononda R, Libhaber E, Dix-Peek T, Peters F, Essop M.
Assessment of myocardial fibrosis by late gadolinium enhancement
imaging and biomarkers of collagen metabolism in chronic rheumatic
mitral regurgitation.
Cardiovasc J Afr
2018;
29
(3): 00–00.
19. Banerjee T, Mukherjee S, Ghosh S, Biswas M, Dutta S, Pattari S,
et al.
Clinical significance of markers of collagen metabolism in rheumatic
mitral valve disease.
PLoS One
2014;
9
(3): e90527.